COVID-19 Vaccine Roll Outs in ASEAN & Asia – Live Updates by Country
(This article will be updated continuously. It was originally published on January 28, 2020. It was last updated on September 27, 2021)
Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations.
Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running live update service to keep businesses involved in ASEAN and Asia updated with the latest relevant regional news.
For specific updates concerning China and related business advisory, please click here.
Please refresh the page to get the latest updates.
ASEAN coronavirus updates (Live updates by country)
Brunei has joined the global Covax scheme and is expecting to have the COVID-19 vaccine in Q1 2021, having sourced enough supplies to cover 50% of the population. Discussions are on-going with other suppliers.
- Brunei recorded 160 new cases and one death on September 27, taking the tallies to 6,700 cases and 38 deaths.
- Brunei saw 254 new cases on September 26, bringing the total to 6,540 cases amid 37 deaths.
- Brunei reported 326 new cases and four deaths on September 25, bringing the totals to 6,286 cases and 37 deaths.
Cambodia is expected to import vaccines from both China and Russia. China’s vaccines are still undergoing clinical trials while Russia has already commenced production. Australia has offered financial support to aid vaccine coverage in several southeast Asia countries including Cambodia.
- Cambodia reported 839 new cases and 18 deaths on September 27, bringing the tallies to 109,926 cases and 2,261 deaths.
- Cambodia saw 830 new cases and 25 deaths on September 26, taking the totals to 109,087 cases and 2,243 deaths.
- Cambodia recorded 816 new cases and 21 deaths on September 25, bringing the tallies to 108,257 cases and 2,218 deaths.
Indonesia has commenced vaccinations with just over nine million doses being given to front line workers from last month. China’s Sinovac is in discussions with Indonesia to provide supplies, however, the Government faces difficulties with a large population of 270 million. Indonesia’s Health Ministry’s Disease Control and Prevention Director-General Achmad Yurianto said that vaccinations would only be provided to citizens aged 18-59. The vaccine has also been required to pass halal certification prior to use and it is uncertain how the country can source enough vaccines to reach a sizeable part of its population.
- Indonesia recorded 1,390 new cases and 118 deaths on September 27, bringing the tallies to 4,209,403 cases and 141,585 deaths.
- Indonesia reported 1,760 new cases and 86 deaths on September 26, taking the totals to 4,208,013 cases and 141,467 deaths.
- Indonesia saw 2,137 new cases and 123 deaths on September 25, taking the tallies to 4,206,253 cases and 141,381 deaths.
Laos has been trialing the Russian Sputnik V vaccine and is also in discussions with China about acquiring supplies.
- Laos recorded 622 new cases on September 27, taking the total to 22,441 cases amid 16 deaths.
- Laos reported 292 new cases on September 26, bringing the total to 21,819 cases amid 16 deaths.
- Laos saw 447 new cases on September 25, taking the total to 21,527 cases amid 16 deaths.
Malaysia is to provide vaccines free of charge to its nationals, but foreigners will need to pay for the treatment, according to the Malaysian Minister of Health, Tan Sri Muhyiddin Yassin, who has signed a deal with Pfizer for 12.8 million doses. These will be administered in two stages of 6.4 million people each, with the program to commence in Q1 2021. The country aims to inoculate between 80-100% of its citizens.
- Malaysia saw 13,104 new cases and 278 deaths on September 26, taking the tallies to 2,198,235 cases and 25,437 deaths.
- Malaysia reported 13,899 new cases and 228 deaths on September 25, bringing the totals to 2,185,131 cases and 25,159 deaths.
- Malaysia recorded 14,554 new cases and 250 deaths on September 24, taking the tallies to 2,171,232 cases and 24,931 deaths.
Myanmar is seeking assistance from the Gavi and Covax programs to acquire vaccines, while Australia is also providing financial relief. At present, the Government aims to treat 20 percent of the ‘most at risk’ in the country with vaccines. The Government is struggling with finances and logistics and is also under US sanctions, while cases are surging. The Government has banned the celebration of Christmas and other seasonal celebrations.
- Myanmar reported 1,534 new cases and 62 deaths on September 26, taking the tallies to 458,154 cases and 17,527 deaths.
- Myanmar recorded 1,546 new cases and 52 deaths on September 25, bringing the totals to 456,620 cases and 17,465 deaths.
- Myanmar saw 1,667 new cases and 70 deaths on September 24, taking the tallies to 455,074 cases and 17,413 deaths.
The Philippines aims to commence vaccinations from June 2021 and expects to inoculate about 25 million people (about 25 percent of its population) over the course of the year. The country has been badly affected by the virus and has the second-highest rate in Southeast Asia. The business community has reacted, more than 30 local companies signed an agreement to purchase at least 2.6 million vaccine doses from AstraZeneca in the country’s first such deal to secure coronavirus vaccines, ten days ago. They plan to donate a large part of the doses to the government for its planned vaccination program and use the rest to inoculate their employees.
- The Philippines saw 20,755 new cases on September 26, taking the tally to 2,490,858 cases amid 37,405 deaths.
- The Philippines recorded 16,907 new cases on September 25, bringing the total to 2,470,235 cases amid 37,405 deaths.
- The Philippines reported 18,659 new cases on September 24, taking the tallies to 2,453,328 cases and 37,405 deaths.
Singapore has been working on producing its own ‘Lunar’ vaccine, in a joint venture between the US company Arcturus together with the Duke-NUS medical school. It is a single dose, mRNA shot, developed from genetically engineering COVID-19 genes into an otherwise harmless virus. This technique is marginally safer than other vaccines which rely on dead Covid-19 material to provoke an immune response. The vaccine is expected to be available from Q1 2021. High-risk personnel will receive the vaccine first in a process to be determined by the government.
- Singapore reported 1,939 new cases and two deaths on September 26, bringing the totals to 87,892 cases and 78 deaths.
- Singapore recorded 1,443 new cases and three deaths on September 25, taking the tallies to 85,953 cases and 76 deaths.
- Singapore saw 1,650 new cases and three deaths on September 24, bringing the totals to 84,510 cases and 73 deaths.
Thailand is currently expecting vaccines to be delivered in mid-2021. The doses would cover 13 million people in a population of about 69 million. Thailand’s National Vaccine Institute signed a non-refundable advance market commitment contract worth 2.38 billion baht (US$79 million) with AstraZeneca to reserve the supplies. Discussions are also on-going with Oxford University in the UK to secure a vaccine that could be available in Q1 if trials are completed in time.
- Thailand saw 10,288 new cases and 101 deaths on September 27, taking the tallies to 1,571,926 cases and 16,369 deaths.
- Thailand reported 12,353 new cases and 125 deaths on September 26, bringing the totals to 1,561,638 cases and 16,268 deaths.
- Thailand reported 11,975 new cases and 127 deaths on September 25, taking the tallies to 1,549,285 cases and 16,143 deaths.
Vietnam’s National Institute of Hygiene and Epidemiology (NIHE), a division of Vietnam’s Ministry of Health, has signed an agreement with Medigen Vaccine, a Taipei, Taiwan-based vaccine company to secure the supply of 3 million to 10 million COVID-19 vaccine doses in 2021. Medigen is currently conducting Phase II studies of the vaccine, co-developed with the USA’s National Institutes of Health (NIH), in Taiwan and Vietnam with a view to a Q1 2021 rollout.
Vietnam is also working on producing its own vaccine, with the Institute of Vaccines and Medical Biologicals (IVAC) in Nha Trang City, partnering with New York City-based Icahn School of Medicine and the global health non-profit organization PATH. Phase 1 trials are already underway in Vietnam, while Phases 2 & 3 will be conducted at the beginning of 2021. The institute plans to submit documents for approval to the health ministry as early as April next year and claims to be capable of producing 30 million doses a year, expecting that a national vaccine could be distributed to the general population in October 2021.
- As of September 27, 2021, Vietnam’s Ministry of Health confirmed a total of 766,051 cases of COVID-19. However, 527,926 of the affected patients have recovered and been discharged from hospitals. Vietnam has also recorded 18,758 deaths due to the pandemic. The latest community transmission cases have been reported from Ho Chi Minh City, Binh Duong, Dong Nai, Long An, and Kien Giang among others.
- Vietnam reported 10,011 new cases and 184 deaths on September 26, bringing the tallies to 756,689 cases and 18,584 deaths.
- Vietnam saw 9,706 new cases and 180 deaths on September 25, taking the totals to 746,678 cases and 18,400 deaths.
Other Asian countries and Regions
Afghanistan faces two pandemics at the same time, Covid-19 and Polio. UNICEF is currently embarking on an urgent Polio vaccination program while the country is in talks with both China and Russia oversupplying COVID-19 vaccines. Government-imposed lockdowns increased conflict with the Taliban, and an overall lack of awareness of the disease has prevented many Afghani from obtaining treatment of either.
- Afghanistan has 155,093 cases and 7,201 deaths as of September 27.
- Afghanistan has 155,132 cases and 7,198 deaths as of September 25.
- As of September 24, Afghanistan has 155,019 cases and 7,198 deaths.
Bangladesh will receive 68 million doses of the COVID-19 vaccine from Gavi, which is committed to ensuring at least 20 percent of populations are inoculated. Each complete dose will cost about 200 Taka (US$2). The country is also in discussions with India concerning a further 30 million doses from the Serum Institute at about 450 Taka (US$5). Vaccinations are expected to commence in Q1 2021.
- Bangladesh has 1,552,563 cases and 27,439 deaths as of September 27.
- As of September 26, Bangladesh has 1,551,351 cases and 27,414 deaths.
- Bangladesh has 1,550,371 cases and 27,393 deaths as of September 25.
Bahrain has begun COVID-19 vaccinations for front line personnel using a joint Chinese-UAE Sinopharm product. Roll out among the general population is expected in Q1 2021.
- Bahrain has 274,814 cases and 1,389 deaths as of September 26.
- As of September 25, Bahrain has 274,745 cases and 1,389 deaths.
- Bahrain has 274,676 cases and 1,389 deaths as of September 24.
For specific updates concerning China, please click here.
For a complete overview of China’s vaccine availability please go here.
- China recorded 35 new cases on September 27, taking the total to 96,050.
- China reported 29 new cases on September 26, bringing the total to 96,015.
- China saw 38 new cases on September 25, taking the total to 95,986.
East Timor is receiving assistance from the Gavi Institute.
- East Timor has 19,398 cases and 113 deaths as of September 27.
- As of September 26, East Timor has 19,382 cases and 113 deaths.
- East Timor has 19,350 cases and 113 deaths as of September 25.
Hong Kong will provide COVID-19 vaccines free to all residents, with a vaccine being delivered in stages. The government has said it may take most of 2021 to reach 100 percent coverage for all citizens.
- Hong Kong has 12,197 cases and 213 deaths as of September 27.
- As of September 26, Hong Kong has 12,194 cases and 213 deaths.
- Hong Kong has 12,186 cases and 213 deaths as of September 25.
For a complete overview of India’s vaccine availability please go here.
- India has 33,678,243 cases and 447,225 deaths as of September 26.
- As of September 25, India has 33,651,221 cases and 446,948 deaths.
- Our new India-specific updates can be found here.
Iran is jointly producing a COVID-19 vaccine with Russia, and the product has entered trials. National inoculation is expected to commence in September 2021.
- Iran has 5,547,990 cases and 119,649 deaths as of September 27.
- As of September 26, Iran has 5,533,520 cases and 119,360 deaths.
- Iran has 5,519,728 cases and 119,082 deaths as of September 25.
Iraq is currently in discussions with US company Pfizer concerning supplies of a COVID-19 vaccine. Supplies are expected in Q2 2021.
- As of September 26, Iraq has 1,993,767 cases and 22,110 deaths.
- Iraq has 1,991,628 cases and 22,072 deaths as of September 25.
- Iraq has 1,990,316 cases and 22,039 deaths as of September 24.
Japan is sourcing 145 million doses of vaccine from the United States and the UK and will be delivering them free of charge to all citizens commencing Q1 2021.
- Japan has 1,694,675 cases and 17,482 deaths as of September 27.
- As of September 26, Japan has 1,692,387 cases and 17,453 deaths.
- As of September 25, Japan has 1,689,899 cases and 17,421 deaths.
Jordan is sourcing vaccines from Pfizer and expects to commence vaccinations from Q1 2021.
- As of September 26, Jordan has 819,783 cases and 10,680 deaths.
- Jordan has 818,796 cases and 10,669 deaths as of September 25.
- Jordan has 818,358 cases and 10,653 deaths as of September 24.
Kazakhstan has been developing its own vaccines with ‘Quazcovid’ being admitted by the WHO as a safe candidate. These are currently undergoing trials with a roll out expected in Q2 2021.
- Kazakhstan has 878,990 cases and 11,065 deaths as of September 27.
- Kazakhstan has 877,112 cases and 11,035 deaths as of September 26.
- As of September 25, Kazakhstan has 874,920 cases and 10,999 deaths.
All citizens, including expatriates, will receive COVID-19 vaccines for free. Kuwait is importing one million vaccines from Pfizer, 1.7 million from Moderna, and three million doses of the Oxford-AstraZeneca vaccines and will commence a nationwide program from January.
- As of September 26, Kuwait has 411,484 cases and 2,446 deaths.
- As of September 25, Kuwait has 411,447 cases and 2,445 deaths.
- Kuwait has 411,406 cases and 2,444 deaths as of September 24.
Kyrgyzstan is sourcing vaccines from Russia with the Sputnik V vaccine expected to be rolled out in Q2 2021.
- As of September 27, Kyrgyzstan has 178,317 cases and 2,602 deaths.
- Kyrgyzstan has 178,258 cases and 2,600 deaths as of September 26.
- Kyrgyzstan has 178,202 cases and 2,599 deaths as of September 25.
Lebanon is sourcing vaccines from Pfizer and is expected to take deliveries from mid-February 2021.
- Lebanon has 622,235 cases and 8,286 deaths as of September 26.
- Lebanon has 621,735 cases and 8,277 deaths as of September 25.
- As of September 24, Lebanon has 621,155 cases and 8,268 deaths.
Macao is part of the Covax scheme and is expected to receive 1.4 million doses of vaccine. The product will cost Pataca 300 (US$40). Roll out is expected in late Q1 2021.
- As of August 4, Macau has 63 cases.
- Macau has 59 cases as of July 25.
- As of July 24, Macau has 58 cases.
The Maldives will receive vaccines under the Covax program and will receive enough products to reach 20 percent of its population. Roll out is expected in Q2 2021.
- As of September 26, the Maldives has 84,362 cases and 231 deaths.
- The Maldives has 84,290 cases and 231 deaths as of September 25.
- The Maldives has 84,164 cases and 230 deaths as of September 24.
Mongolia is in discussions with Astra-Zeneca to purchase COVID-19 vaccines and is also part of the Covax scheme. Roll out is expected in Q2 2021.
- As of September 27, Mongolia has 296,766 cases and 1,225 deaths.
- Mongolia has 294,775 cases and 1,206 deaths as of September 26.
- As of September 25, Mongolia has 292,591 cases and 1,189 deaths.
Nepal will source COVID-19 vaccines under the Covax program and will also purchase supplies from India. The rollout is expected from Q2 2021.
- As of September 27, Nepal has 792,367 cases and 11,103 deaths.
- Nepal has 791,392 cases and 11,096 deaths as of September 26.
- As of September 25, Nepal has 790,662 cases and 11,087 deaths.
North Korea is expected to receive Covid-19 vaccines from China, with rumors that North Korean Leader Kim Jong-Un has already received treatment as part of medical trials.
- North Korea has reported its first case on July 25, the city of Kaesong is under lockdown.
Oman has sourced COVID-19 vaccines from Gavi and is buying additional supplies from Astra-Zeneca and Pfizer. Roll out will commence from January 2021 with each shot costing 10 Rial (US$24).
- As of September 27, Oman has 303,673 cases and 4,095 deaths.
- Oman has 303,639 cases and 4,095 deaths as of September 26.
- Oman has 303,551 cases and 4,093 deaths as of September 23.
Pakistan is also suffering from a Polio epidemic and is struggling with dealing with both. However, it has stated it will provide the vaccine for free with national inoculations to start from April 2021.
- Pakistan has 1,240,425 cases and 27,597 deaths as of September 27.
- Pakistan has 1,238,668 cases and 27,566 deaths as of September 26.
- As of September 25, Pakistan has 1,236,888 cases and 27,524 deaths.
Israel is currently negotiating with the UAE to provide 1.5 million doses of vaccine to Palestine. The product is expected to be the Russian Sputnik V treatment and should be available to Palestinians in Q2 2021.
- Palestine has 396,746 cases and 4,025 deaths as of September 26.
- As of September 25, Palestine has 395,677 cases and 4,018 deaths.
- Palestine has 394,683 cases and 3,997 deaths as of September 24.
Qatar has signed an agreement with Moderna to provide Covid-19 vaccines and has also signed deals with Pfizer and BioNTech. These will be made available from late Q1 2021.
- Qatar has 236,388 cases and 605 deaths as of September 27.
- Qatar has 236,298 cases and 605 deaths as of September 26.
- As of September 25, Qatar has 236,231 cases and 604 deaths.
A complete overview of the availability and production of Russian Covid-19 vaccines and costs can be found here.
- As of September 27, Russia has 7,443,149 cases and 204,679 deaths.
- Russia has 7,420,913 cases and 203,900 deaths as of September 26.
- Our new Russia-specific updates here.
Saudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO) said last week that it had signed an agreement with the German biopharmaceutical company CureVac to provide Covid-19 vaccine. It plans to cover 70 percent of its population by the end of 2021 with treatment being available for free. The initial roll out is expected to be at the end of Q1 2021.
- As of September 27, Saudi Arabia has 546,985 cases and 8,704 deaths.
- Saudi Arabia has 546,926 cases and 8,699 deaths as of September 26.
- As of September 25, Saudi Arabia has 546,882 cases and 8,694 deaths.
South Korea has reached a deal with AstraZeneca to purchase its coronavirus vaccine candidate and is in final talks with global drug-makers including AstraZeneca, Pfizer Inc, and Johnson & Johnson over their vaccines. It launched a preliminary review of AstraZeneca’s product in October for potential fast-track approval. Roll out is expected in Q1 2021.
- South Korea has 303,553 cases and 2,456 deaths as of September 27.
- South Korea has 301,172 cases and 2,450 deaths as of September 26.
- As of September 25, South Korea has 298,402 cases and 2,441 deaths.
Sri Lanka is to receive 4.2 million doses of the COVID-19 vaccine from Gavi, enough to cover 20 percent of the population. It has not yet released information on when these will be made available.
- As of September 26, Sri Lanka has 513,609 cases and 12,680 deaths.
- Sri Lanka has 512,531 cases and 12,609 deaths as of September 25.
- Sri Lanka has 511,372 cases and 12,530 deaths as of September 24.
Taiwan has been developing its own vaccine and is also part of the Covax scheme. It has stated it will be able to manufacture enough of its own product for 50 percent population coverage with roll-out expected in Q1 2021.
- Taiwan has 16,198 cases and 842 deaths as of September 27.
- Taiwan has 16,189 cases and 841 deaths as of September 26.
- As of September 25, Taiwan has 16,181 cases and 841 deaths.
Turkey has purchased 50 million doses of China’s Cornavac, manufactured by Sinopharm. These will be made available for free to the most at-risk population, inoculations start on December 11. Other treatments will be purchased and made available via medical outlets during the year and sold at cost price, and are likely to include products from Pfizer and Russia.
- Turkey has 7,039,500 cases and 63,166 deaths as of September 26.
- As of September 25, Turkey has 7,013,639 cases and 62,938 deaths.
- Turkey has 6,987,494 cases and 62,745 deaths as of September 24.
United Arab Emirates
The UAE is expected to authorize the use of China’s Sinopharm vaccine which is nearing the end of its clinical trials in the Emirates. The UAE’s Prime Minister, Sheikh Mohammed bin Rashid Al Maktoum was inoculated as part of the testing. Roll out is expected in Q1 2021. The UAE is also manufacturing the vaccine and hopes to produce between 75-100 million doses during the year.
- The UAE has 734,894 cases and 2,090 deaths as of September 26.
- The UAE has 734,596 cases and 2,089 deaths as of September 25.
- As of September 24, the UAE has 734,275 cases and 2,086 deaths.
Uzbekistan has been trailing China’s Anhui Zhifei Longcom Biopharmaceutical vaccine in addition to vaccines made by China’s Sinopharm and Russia’s Sputnik V. Roll out is expected in Q1 2021.
- As of September 26, Uzbekistan has 172,090 cases and 1,222 deaths.
- Uzbekistan has 171,588 cases and 1,218 deaths as of September 25.
- As of September 24, Uzbekistan has 171,080 cases and 1,212 deaths.
Yemen is suffering from war and diseases such as diphtheria, while local politicians have made wild claims that the country will develop its own COVID-19 vaccine. It is a member of the Gavi program and relief is likely to come from humanitarian sources.
- Yemen has 8,934 cases and 1,694 deaths as of September 26.
- As of September 25, Yemen has 8,891 cases and 1,682 deaths.
- Yemen has 8,861 cases and 1,673 deaths as of September 24.
ASEAN Briefing is produced by Dezan Shira & Associates. The firm assists foreign investors throughout Asia and maintains offices throughout ASEAN, including in Singapore, Hanoi, Ho Chi Minh City, and Da Nang in Vietnam, Munich, and Esen in Germany, Boston, and Salt Lake City in the United States, Milan, Conegliano, and Udine in Italy, in addition to Jakarta, and Batam in Indonesia. We also have partner firms in Malaysia, Bangladesh, the Philippines, and Thailand as well as our practices in China and India. Please contact us at email@example.com or visit our website at www.dezshira.com.